Does BINIMETINIB Cause Hyperkeratosis? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hyperkeratosis have been filed in association with BINIMETINIB (MEKTOVI). This represents 0.2% of all adverse event reports for BINIMETINIB.
11
Reports of Hyperkeratosis with BINIMETINIB
0.2%
of all BINIMETINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Hyperkeratosis From BINIMETINIB?
Of the 11 reports, 1 (9.1%) required hospitalization.
Is Hyperkeratosis Listed in the Official Label?
Yes, Hyperkeratosis is listed as a known adverse reaction in the official FDA drug label for BINIMETINIB.
What Other Side Effects Does BINIMETINIB Cause?
Off label use (902)
Death (719)
Nausea (657)
Fatigue (562)
Diarrhoea (521)
Product use in unapproved indication (508)
Pyrexia (490)
Neoplasm progression (387)
Vomiting (375)
Rash (360)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which BINIMETINIB Alternatives Have Lower Hyperkeratosis Risk?
BINIMETINIB vs BIOFLAVONOIDS
BINIMETINIB vs BIOTIN
BINIMETINIB vs BIPERIDEN
BINIMETINIB vs BIRCH TRITERPENES
BINIMETINIB vs BISACODYL